ELSOMED - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 485,566 | 232,338 | 1,154,730 | 467,730 | 240,965 | 461,225 | 256,705 | 170,641 |
| Profit before tax | 73,977 | -18,098 | 533,824 | 188,854 | 18,892 | 75,899 | 34,488 | 17,505 |
| Net profit | 62,943 | -18,098 | 453,750 | 161,779 | 16,449 | 62,503 | 29,297 | 14,704 |
| Equity | 125,181 | 71,789 | 465,539 | 227,318 | 243,767 | 66,270 | 95,567 | 147,270 |
| Liabilities | 13,147 | 16,173 | 118,174 | 234,019 | 136,477 | 332,489 | 69,387 | 45,787 |
| Non-current assets | 263 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 138,065 | 87,961 | 583,712 | 461,337 | 380,121 | 398,672 | 164,845 | 193,107 |
| Total assets | 138,328 | 87,962 | 583,713 | 461,337 | 380,121 | 398,672 | 164,845 | 193,107 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 52,538 | 74,244 | 34,876 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +439.2% | -52.2% | +397.0% | -59.5% | -48.5% | +91.4% | -44.3% | -33.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 45.5% | -20.6% | 77.7% | 35.1% | 4.3% | 15.7% | 17.8% | 7.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 50.3% | -25.2% | 97.5% | 71.2% | 6.7% | 94.3% | 30.7% | 10.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.0% | -7.8% | 39.3% | 34.6% | 6.8% | 13.6% | 11.4% | 8.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.2% | -7.8% | 46.2% | 40.4% | 7.8% | 16.5% | 13.4% | 10.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.3 | 1.0 | 0.6 | 5.0 | 0.7 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 485,566 | 232,338 | 1,154,730 | 374,184 | 137,694 | 345,927 | 181,199 | 85,321 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ELSOMED - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-16 | 0.04 |
| 2026-05-17 | 2026-06-02 | 0.04 |
| 2026-01-16 | 2026-01-19 | 30.80 |
ELSOMED - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ELSOMED, UAB (code 303378588) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €170.6K and net profit of €14.7K, with a profit margin of 8.6%. Revenue declined by 33.5% year on year and by 63.0% over two years, following €256.7K in 2024 and €461.2K in 2023. Profitability also softened over the period, although the business remained profitable each year, with net profit of €62.5K in 2023 and €29.3K in 2024. The balance sheet strengthened in 2025 as equity rose to €147.3K, while liabilities decreased to €45.8K. Total assets stood at €193.1K, compared with €164.8K in 2024 and €398.7K in 2023. Key 2025 ratios show return on equity of 10.0%, return on assets of 7.6%, a debt-to-equity ratio of 0.31, and asset turnover of 0.88x. Revenue per employee was €85.3K and profit per employee €7.4K.